ABSTRACT. Gastro-resistant capsules are often used for several purposes, such as protection of unstable drugs in acid medium to the action of gastric fluids or protection of the gastric mucosa to irritants drugs. The aim of this study was to verify the variation of preparations of capsules coating with cellulose acetate phthalate and methacrylic acid copolymer, without drug addition, in 7-10% coating concentrations, prepared manually with four or five immersions in tested coating solution. Results were analyzed considering the formulation's disintegration test. Within the context of formulations under analysis, it was observed that the capsules coated with cellulose acetate phthalate 10% complied with the pharmacopeia's disintegration specifications. However, capsules coated with methacrylic acid copolymer did not show accordance with the pharmacopeia's specifications. The results emphasize the need for the standardization of coating methodology.
Introduction
The production of hard gelatin capsules is on the increase. In fact, the above pharmaceutical mode is highly accepted and, similar to tablets, it is currently the most common mode of oral drug administration (MARTINS; OLIVEIRA, 2003; PINA et al., 1996 PINA et al., , 1997 .
Gastrointestinal resistant-capsules are frequently employed to protect unstable drugs against gastric fluids in an acid medium. They are also used in drugs that cause nausea or vomit, or in drugs that irritate the gastric mucous when released in the stomach. They may also be used in drugs that should only produce their greatest effect in the duodenum or the jejunum and when it is necessary that the active substances are available after a certain period (FERREIRA, 2002) .
The release speed of the hard gelatin capsule should be modified so that the drugs could be encapsulated. This may occur through the disintegration of the capsule and the dissolution of the drug in neutral and/or base pH (rates may be found in the enteric medium) which may be obtained by applying a gastroresistant coating. Since the literature provides few studies on coating application in such pharmaceutical forms, the development of methods for the coating of hard gelatin capsules is a promising research field (MARTINS; OLIVEIRA, 2003) .
Pharmaceutical film-coating technology is foregrounded on polymers in solution or dispersed in an aqueous medium or in organic solvents. During the last years several varieties of film-forming polymers have been evaluated and employed for the coating of solid oral capsules (BUNHAK et al., 2007 The present study investigated the variation in the preparation of cellulose acetate phthalate and methacrylic acid copolymer coating (Rheapol L 100 ® ), without drug addition, in a magistral pharmacy: standardized the pharmacotechnical procedures to coat hard gelatin capsules and evaluated the efficiency of such coating through disintegration tests.
Material and methods

Material and coating preparation
Samples of coated capsules, codified by letters, were donated by a magistral pharmacy (Table 1) .
Coating compositions comprised 8% (p/v) cellulose acetate phthalate, 1.5% (p/v) castor oil, 3% (p/v) propylenoglycol, 45% acetone and alcohol 96 GL to complete 100 mL (Formulation A/8). Concentrations with 9 and 10% (p/v) of cellulose acetate phthalate were also employed (Formulations A/9 and A/10).
Hard gelatin capsules, size 0, with inert matter, were also used for coating.
Acetate phthalate was solved in acetone and propylenoglycol, castor oil and ethyl alcohol were subsequently added. Capsules were given four coating applications with cellulose acetate phthalate solution 8% (p/v)(A/8/4) and 4 and 5 applications with solutions 9 (A/9/4 and A/9/5) and 10% (p/v) (A/10/4 and A/10/5), respectively.
The second coating type tested comprised Rheapol L 100 ® 7% (p/v) and was composed by 1.9% carbowax 400, acetone/alcohol 96 GL (50:50-v:v) in sufficient amount to complete 100 mL. Methacrylic acid copolymer was dissolved in 90 mL of the acetone/alcohol mixture. Carbowax 400 was added and final volume was adjusted to 100 mL. Capsules were immersed four times in the coating solution and dried, obtaining Formulation B/7/4. Rheapol L 100 ® was also tested at concentration 9% (p/v) with four or five applications to capsules, obtaining Formulations B/9/4 and B/9/5, respectively.
There was a 30 min.-interval between applications and room temperature was used for drying on a plane surface.
Coating preparation was made by manual shaking at room temperature. Experimental methods
Mean weight of content
Weight of capsules followed criteria established by the Brazilian Pharmacopeia (BRASIL, 2010) for hard capsules. Twenty units were separated and weighed; contents were removed; they were adequately cleansed and weighed again. Content weight was the difference between the full and empty capsule. Allowed variation was ± 10% (mean weight less than 300 mg) when compared to mean weight. No more than two units which did not comply with specific limits may be tolerated. However, no unit could be double the percentages indicated either for more or for less.
Gastro-resistance assays
Disintegration assays verified the gastro-resistance characteristics of the coated products. Six capsules were placed in chlorohydric acid 0.1 mol L -1 and maintained at 37°C ± 1°C. After 60 minute in the acid medium, the capsules were immersed in a phosphate solution pH 6.8 ± 0.1 and maintained at 37°C ± 1°C till total disintegration. In current assay disintegration was complete when no residue remained, except fragments of insoluble coating or matrix. Gastro-resistant capsules were those that remained intact, without any cracks or mollification during the 60 min.-period they were exposed to the simulated gastric fluid and failed to disintegrate in the simulated intestinal fluid up to 45 min. Results were undertaken in triplicates following 
Results and discussion
Prior to coating application, capsules were characterized by mean content weight. Table 2 shows the rates of mean weight and its lower and higher limits. According to the Brazilian Pharmacopeia (BRASIL, 2010), acceptable variation of capsule content with less than 300 mg was ± 10%. All tested capsules were within the specified limits.
The disintegration assay verified whether tablets and capsules disintegrated within specified time when six units were exposed to specific apparatus in the experimental conditions described above (BRASIL, 2010) . According to the Brazilian Pharmacopeia (BRASIL, 2010), complete disintegration occurred when no capsule residue remained in the metallic sieve of the disintegration apparatus, except fragments of insoluble capsules. Units were disintegrated when they were transformed into a pasty mass during the test and remained on the apparatus's sieve.
All capsules disintegrated in Formulation A/8/4 during their exposure to chlorohydric acid in the test done in triplicate.
Capsules in Formulation A/9/4 showed disintegration signs when exposed to chlorohydric acid, although all capsules of the same formulation disintegrated in the enteric medium.
Regarding formulation A/9/5, one capsule showed signs of disintegration when exposed to chlorohydric acid, whereas all capsules of the same formulation disintegrated in the enteric medium.
The capsules of Formulations A/10/4 and A/10/5 complied with the specific requirements of the Brazilian Pharmacopeia (BRASIL, 2010) since no signs of disintegration in the acid medium occurred and all capsules disintegrated in the buffer medium at pH 6.8. On the other hand, of the three samples (B/7/4; B/9/4; B/9/5) capsules coated with Rheapol L 100 ® , at least one not resist in the acid stage, but totally disintegrated in the buffer stage in less than 45 min when test was undertaken in triplicate.
Capsules of Formulation A (coated with cellulose acetate phthalate) were more gastro-resistant than those in Formulation B (methacrylic acid copolymer), especially those of stocks A/10/4 and A/10/5, that complied with the requirements of disintegration tests.
Data suggest that only cellulose acetate phthalate among the gastro-resistant agents employed by the magistral pharmacy was enterically adequate for capsule coating.
The process of obtaining extemporarily enteric capsules adequate has many variables conditioned to technique and to handling which may impact the performance of other stocks.
It is thus recommendable that each formulation or batch to gastrointestinal resistant-capsules obtained extemporarily in a magistral pharmacy should undergo a disintegration and/or dissolution test to evaluate its performance and to verify whether the criteria of pharmacopeia acceptance are attended to (ROCIO et al., 2012) .
Several polymeric compounds are used in the enteric coating of pharmaceutical product. The compounds should be resistant to the pH of the stomach acid and sensitive to that of the intestine tract, which will guarantee the disintegration of the polymer followed by dissolution of the drug in the pharmaceutical form. The compounds should be resistant to the pH of the stomach acid and sensitive to that of the intestine tract, which will guarantee the disintegration of the polymer will guarantee the disintegration of the polymer followed by dissolution of the drug in the pharmaceutical form.Studies by Rowe et al. (2003) showed that filmogenic polymers used in enteric coating of capsules were cellulose acetate phthalate and methacrylic acid copolymer which were only soluble in intestine fluids as from pH 6.0.
In the experiments by Prista et al. (1995) with solutions composed of 8 parts cellulose acetate phthalate, 4 parts ethyl phthalate and 88 parts acetone, capsules were immersed four times in the solution and hot air-dried between applications of each two successive layers. Results showed that cellulose acetate phthalate coating is adequate to obtain gastro-resistant and entero-soluble hard gelatin capsules.
Disintegration test applied to hard gelatin capsules with gastro-resistant contents performed by MarquesMarinho et al. (2009) showed that only capsules coated with A-type methacrylic acid copolymer complied with the requirements of disintegration tests. However, stocks of cellulose acetate phthalate coated capsules were not gastro-resistant.
Conclusion
Current research shows that magistral pharmacies need comply with rules in the manufacture of gastroresistant capsules. The latter should be protected up to the time they reach the activity site and thus their therapeutic efficiency may be guaranteed. When pharmacists make available a drug, they should be absolutely sure that they are complying with quality rules; otherwise, they should not dispense the drugs.
The present study suggested standardization of gastro-resistant capsules with two types of coating, however, of the eight stocks tested, only the formulations A/10/4 and A/10/5 are a delayed release system. Results show that the preparation of capsules by alternative processes produced a 75% gastroresistant failure of the produced stocks.
